Clariant opens new high throughput experimentation lab in Texas, US

10:57 AM, 7th September 2019

HOUSTON, US: Clariant has opened its next High Throughput Experimentation (HTE) Laboratory in Houston, Texas - the energy capital of US. The location is key as the new facility will be the first of its kind supporting the oil & gas industry, offering new and sophisticated solutions for customers.

This lab is part of a global Clariant initiative to expand HTE capabilities to all Clariant Business Units, including direct support for oil services in North America, the Asia Pacific region, Latin America, Africa and the North Sea.

HTE is an innovative approach and methodology where automated instrumentation, specialized software tools and alternative techniques are able to provide optimized formulations in a rapid timeframe. While it has been widely used in other industries for many years, Clariant is the first company to adopt this technology for the Oil & Gas industry as a standard tool.

“This is an exciting, and unique, new offering for the Oil & Gas industry, and, being in such close proximity to so many customers, means that we can offer superior, faster service,” said Jonathan Wylde, Head of Innovation and Application Development Clariant Oil and Mining Services. “With our state-of-the-art equipment in the lab, advanced research concepts, and potential customization for specific projects, our researchers are now able to identify new formulations and synergistic blends for specific customer crudes, ultimately reducing the time to market for new products.”

As a new addition to the existing lab located at Clariant Oil Services Headquarters, Clariant specialist chemists and innovation experts are now able to utilize miniaturization, parallelization, intelligent design and enhanced analytics – all proven to increase efficiency and productivity. The facility will help to meet current and outstanding needs in the Oil & Gas industry, with special emphasis on pour point depressants, hydrate inhibitors, asphaltene inhibitors, corrosion inhibitors and scale inhibitors.

The HTE lab opening comes after significant investment at Clariant’s Midland, Texas and Clinton, Oklahoma facilities, putting the company at the forefront of solutions to market needs, and further highlighting its commitment to grow with US and global customers.

“Static environments, like factory assembly lines, are easy to automate. In contrast, an R&D environment requires a special solution to keep pace with its dynamic nature. One must have a highly flexible concept with very short integration times to reach automated efficiency. As a global leader in the field, we have designed our HTE lab with ‘standardized flexibility’ to achieve this,” said Lucius Kemp, Clariant’s Global Head of High Throughput Experimentation, Group Technology and Innovation.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Johnson Matthey appoints new chief executive for battery material biz

LONDON, UK: Johnson Matthey has appointed Christian Gunther as chief executive of its battery materials business. In this new and important role, Chr ...

Read more
FDA approves Boehringer's lung disease drug

MARYLAND, US: The US Food and Drug Administration on Friday approved German drugmaker Boehringer Ingelheim's Ofev capsules for a rare lung disorder. ...

Read more
DSM appoints new president for DSM Engineering Plastics

SINGAPORE: Royal DSM has appointed Shruti Singhal as President DSM Engineering Plastics, effective 1 October 2019. Shruti, a US national, joined DSM ...

Read more
Clariant’s new CFA masterbatches cut plastics content in packaging by 10%

MUTTENZ, SWITZERLAND: Packaging manufacturers and brand owners trying to reach sustainability goals and reduce costs are expressing keen interest in t ...

Read more
Evonik invests in Chinese medical implants 3D-printing start-up

ESSEN, GERMANY/SHANGHAI, CHINA: Evonik Venture Capital has invested in a 3D-printing start-up in China that makes implants for neuro and spine surgery ...

Read more
Sumitomo Dainippon Pharma to invest $3 bn in Swiss Roivant

TOKYO, JAPAN: Sumitomo Dainippon Pharma Co will pay $3 billion for a 10% stake in Swiss drugmaker Roivant Sciences Ltd and interests in five of its bi ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X